2020 IPO

Compass Pathways Stock
Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.
Sign up today and learn more about Compass Pathways Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Compass Pathways Stock
Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.
Funding History
January 2017 | $4.0M |
---|
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase